医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

iMDsoft Launches MetaVision SafeTrack, Its Mobile Electronic Observation Solution

2015年10月07日 PM05:44
このエントリーをはてなブックマークに追加


 

DÜSSELDORF, Germany

iMDsoft® announced the release of MetaVision SafeTrack™, its new mobile electronic observation solution. The solution automates Modified Early Warning Scores (MEWS) calculations, nursing assessments and escalations, ensuring timely intervention for patient deterioration.

Electronic observation systems have been proven to reduce length of stay and increase clinical attendance to patients. Additionally, digital recording of early warning scores is faster and more accurate.

Hospitals using MetaVision SafeTrack will enjoy all the advantages of a mobile electronic observation solution. Nurses will no longer manually document vital signs and observations, eliminating the issues associated with paper charting, such as illegibility and risk of error. The solution calculates all the NHS early warning scores, supporting different departments. Scores can be adjusted for individual patients as the need arises. The system provides smart alerts and nursing assessments for sepsis, AKI, VTE and more. Our rule-based engine incorporates observations with other information such as lab results as soon as they are available, which helps identify patients at risk for dangerous conditions, independent of the bedside clinician.

Escalation paths help rescue patients from possible deterioration and provide the relevant caregivers with real-time clinical and location information. Doctors, senior nurses, administrators, and outreach teams define which patients and data they need to access. Hospital management can use the system to generate reports needed for studying key performance indicators such as escalations and EWS per department.

MetaVision SafeTrack offers an unparalleled level of flexibility. Hospitals determine which scores, smart alerts and reports are most beneficial for their requirements. Integration with bedside devices in high acuity settings and hospital information systems such as PAS and Electronic Patient Records (EPR) makes this a suitable solution for hospitals looking to complement their existing IT infrastructure with an electronic observation system.

Based on the MetaVision EPR platform, MetaVision SafeTrack is able to expand to meet changing requirements. The solution can grow to include additional functionality such as nursing documentation, doctor documentation and medication management, all the way to a hospital-wide electronic patient record.

“The introduction of MetaVision SafeTrack is the next natural step in our commitment to helping provide better care for critical patients across the hospital,” said Lars-Oluf Nielsen, CEO of iMDsoft. “Our expertise in high acuity environments and data integration has paved the way for this innovative solution.”

MetaVision SafeTrack will be presented at ANZICS in Auckland, New Zealand, 29-31 October; at EHI Live 2015 in Birmingham, the UK, 3-4 November; and at HISI in Dublin, Ireland, 25-26 November.

Learn more about MetaVision SafeTrack.

Meet with us at EHI Live 2015.

About iMDsoft

iMDsoft is a leading provider of Clinical Information Systems for critical, perioperative, and acute care environments. The company’s flagship family of solutions, the MetaVision Suite, was first implemented in 1999. Hospitals and health networks worldwide use MetaVision to improve care quality and enhance financial results. The system promotes compliance with protocols and best practices, streamlines reporting and supports clinical research. To learn more about iMDsoft, visit www.imd-soft.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151007005552/en/

CONTACT

iMDsoft
Anne Belkin, +972-3-7682812
VP Marketing
anne.belkin@imd-soft.com

同じカテゴリーの記事 

  • Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions
  • ReNAgade Therapeutics宣布在ASGCT第27届年会上发表演讲
  • ReNAgade TherapeuticsがASGCT第27回年次総会でのプレゼンテーションの内容を発表
  • BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
  • The 2024 Japan Prize Award Ceremony Is Held with Their Majesties the Emperor and Empress of Japan in Attendance